Skip to main content
. 2022 Jun 9;6:36. doi: 10.1038/s41698-022-00276-6

Fig. 4. Analysis of BRCA1 promotor-hypermethylation.

Fig. 4

a Percentages of strongly and moderately hypermethylated tumors pan-cancer and in specific cancer types. Top line: number of methylated tumors of each cancer type. b Association of methylation status with HRD-positivity (HRDsum ≥ 42). All strongly hypermethylated tumors and 43% of the moderately hypermethylated tumors were HRD-positive.